Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with, or are suspected to have, myeloma or a related plasma cell disorder
- People who are already scheduled to have a blood or bone marrow sample taken for diagnosis, monitoring, or follow-up purposes, whether before, during, or after myeloma treatment
- People aged 18 years or older
- People who are willing to agree to an extra sample being collected at the same time as their scheduled blood or bone marrow sampling
Who may not be able to join:
- People who are unable to provide their own consent to participate
- People who have a known active infectious disease (such as HIV, Hepatitis B, Hepatitis C, or COVID-19) that could pose a risk to laboratory staff or processes when the sample is used
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 020 3186 5275
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cell viability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.